CSTL:NASDAQ, Castle Biosciences, Inc.

CSTL stock overview

Castle Biosciences, Inc. (CSTL:NASDAQ) closed at $32.75 on November 16, 2026, down 3.08% on the day. The stock trades 26.0% below its 52-week high of $44.28 and 84.8% above its 52-week low of $17.72. Over the past year, it lost 3.5%. Castle Biosciences, Inc. is part of the Health Care sector (Medical Specialities).

Key figures

Price
$32.75
Day change
-3.08%
Volume
652,286
Average volume
382,339
Market cap
1B+
52-week range
$17.72 – $44.28
50-day average
$34.35
200-day average
$28.19

Price action over the past year

In 252 trading sessions since November 14, 2025, CSTL closed higher on 132 days (52%). Its best day was August 19, 2026 (+11.33%) and its worst was May 7, 2026 (-22.26%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

CSTL news

About Castle Biosciences, Inc.

Castle Biosciences Inc is a United States-based company engaged in developing and commercializing diagnosis and prognostic tests for dermatologic cancers. Its non-invasive products utilize algorithms to provide an assessment of a patient's specific risk of metastasis or recurrence of their cancer. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.

Similar stocks

Find more stocks like CSTL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.